The knockdown of methyltransferase-like 3 (METTL3) in pancreatic cancer greatly improved sensitivity to drugs such as 5-fluorouracil, cisplatin, gemcitabine, and irradiation. The gene discussed is METTL3; the disease is familial pancreatic carcinoma.